This grant is for research projects that study the long-term side effects of cancer treatments. It aims to understand why these side effects happen and how they can be prevented or reduced. The research should focus on identifying the biological mechanisms behind these side effects and developing ways to measure and test new treatments in clinical trials.
Who it's for: This grant is for a wide range of organizations, including government bodies, nonprofits, educational institutions, private companies, and tribal organizations. It's ideal for those with a focus on cancer research, particularly in understanding and mitigating the long-term side effects of cancer therapies.
More details
Likely Disqualifiers
- Lack of focus on cancer therapy-induced adverse sequelae
- No collaborative research component
- Inadequate mechanistic or translational research approach
- Failure to include clinical phenotyping
- Non-compliance with NIH guidelines
What You May Need
- Detailed research proposal
- Collaborative research plan
- Mechanistic study design
- Translational endpoints
- Clinical phenotyping strategy
- Budget justification
- Institutional support letter
- NIH biosketches for key personnel
- Letters of collaboration
- Human subjects research plan (if applicable)
- Animal welfare assurance (if applicable)
Cautions
- Ensure the project aligns with NIH's focus on cancer therapy-induced adverse sequelae.
- Projects must include a strong translational component.
- Adhere to all NIH application guidelines and deadlines.
Generated from official source details for readability
Eligibility
Eligible Applicant Types
Additional Criteria
This grant is for a wide range of organizations, including government bodies, nonprofits, educational institutions, private companies, and tribal organizations. It's ideal for those with a focus on cancer research, particularly in understanding and mitigating the long-term side effects of cancer therapies.
Overview
This grant is for a wide range of organizations, including government bodies, nonprofits, educational institutions, private companies, and tribal organizations. It's ideal for those with a focus on cancer research, particularly in understanding and mitigating the long-term side effects of cancer therapies.
Likely Disqualifiers
- Lack of focus on cancer therapy-induced adverse sequelae
- No collaborative research component
- Inadequate mechanistic or translational research approach
- Failure to include clinical phenotyping
- Non-compliance with NIH guidelines
Use of Funds
Funds can be used for conducting research on the mechanisms of cancer therapy side effects, developing clinical measures, and testing interventions to prevent or reduce these side effects. This includes costs related to personnel, equipment, and other research-related expenses.
Cost Sharing
Not Required
Important Dates
- Posted
- Nov 6, 2024
- Deadline
- Jan 7, 2028(573 days)
- Archive Date
- Feb 12, 2028
- Last Updated
- Nov 6, 2024
- Est. Award Date (AI estimate)
- Spring 2028
Application Checklist
- Confirm eligibility of your organization type
- Develop a detailed research proposal focusing on cancer therapy side effects
- Plan collaborative research with appropriate partners
- Design mechanistic and translational study components
- Prepare a budget and justification
- Gather institutional support and letters of collaboration
- Complete NIH biosketches for all key personnel
- Prepare human subjects or animal welfare documentation if needed
- Review NIH guidelines for application submission
- Submit the application by January 7, 2028